butyrate + vitamin d3 + saffron extract Capsules

Country of origin
European Union
Recommended use
Nervous system support
Product description
It is a novel nutritional supplement for the treatment of the non-kinetic symptoms of patients with Parkinson’s Disease and Neurodevelopmental Disorders. Sedoaspis is based on postbiotics that act on the Gut Brain Axis.
Manufacturer #25987

This manufacturer is a leading CTD dossier owner and manufacturer, operating for over two decades, specializes in the development and promotion of nutraceuticals, medical foods, and food supplements. Their focus is on specific therapeutic areas and market needs. With a strong European presence and a global network, they offer tailor-made solutions. Their key therapeutic areas include ophthalmology, neurology, and rheumatology. The company also provides products for general health, dermatology, endocrinology, gastrointestinal, and orthopedic & pain management. They produce a range of dosage forms including solids, orals, and liquids. Their production lines are compliant with EU and US GMP standards, ensuring quality and safety. While no specific patents are mentioned, the company's focus on unique products suggests a commitment to innovation and potentially protected intellectual property.

None